NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients

Critical Care Medicine

Volumn 33, Issue 5, 2005, Pages 1001-1007

  Roch, Antoine ^a   Allardet Servent, Jérôme ^a   Michelet, Pierre ^a   Oddoze, Christiane ^a   Forel, Jean Marie ^a   Barrau, Karine ^b   Loundou, Anderson ^b   Perrin, Gilles ^a   Auffray, Jean Pierre ^a   Portugal, Henri ^a   Papazian, Laurent ^a  

^a Hopitaux Sud AP HM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Brain natriuretic peptide; Cardiac dysfunction; Mortality; N terminal pro brain natriuretic peptide, intensive care unit; Septic shock

Indexed keywords

ATROPINE METHYL BROMIDE; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; LACTIC ACID; NERVE PROTEIN; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TROPONIN I;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; DEMOGRAPHY; DISEASE MARKER; FEMALE; HEART DISEASE; HEART INDEX; HEART OUTPUT; HEART WORK; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEPTIC SHOCK; AGED; BLOOD; BLOOD PRESSURE; CARDIOMYOPATHY; MIDDLE AGED; ROC CURVE;

AGED; BLOOD PRESSURE; CARDIOMYOPATHIES; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; ROC CURVE; SHOCK, SEPTIC; TROPONIN I;

EID: 21044437660     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000162561.82012.E9     Document Type: Article

References (45)

1. Annane D, Aegerter P, Jars-Guincestre MC, et al: Current epidemiology of septic shock: The CUB-Rea Network. Am J Respir Crit Care Med 2003; 168:165-172
2. Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490
3. Ellrodt AG, Riedinger MS, Kimchi A, et al: Left ventricular performance in septic shock: Reversible segmental and global abnormalities. Am Heart J 1985; 110:402-409
4. Jardin F, Brun-Ney D, Auvert B, et al: Sepsis-related cardiogenic shock. Crit Care Med 1990; 18:1055-1060
5. Vieillard-Baron A, Schmitt JM, Beauchet A, et al: Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology 2001; 94:400-406
6. Vieillard-Baron A, Prin S, Chergui K, et al: Hemodynamic instability in sepsis: Bedside assessment by Doppler echocardiography. Am J Respir Crit Care Med 2003; 168:1270-1276
7. Parker MM, McCarthy KE, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131
8. Poelaert J, Declerck C, Vogelaers D, et al: Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997; 23:553-560
9. Munt B, Jue J, Gin K, et al: Diastolic filling in human severe sepsis: An echocardiographic study. Crit Care Med 1998; 26:1829-1833
10. Bouchard MJ, Denault A, Couture P, et al: Poor correlation between hemodynamic and echocardiographic indexes of left ventricular performance in the operating room and intensive care unit. Crit Care Med 2004; 32:644-648
11. Jardin F, Valtier B, Beauchet A, et al: Invasive monitoring combined with two-dimensional echocardiographic study in septic shock. Intensive Care Med 1994; 20:550-554
12. Magga J, Marttila M, Mantymaa P, et al: Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology 1994; 134:2505-2515
13. Wiese S, Breyer T, Dragu A, et al: Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: Influence of angiotensin II and diastolic fiber length. Circulation 2000; 102:3074-3079
14. Hunt PJ, Espiner EA, Nicholls MG, et al: Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. J Clin Endocrinol Metab 1996; 81:3871-3876
15. Maisel AS, Krishnaswamy P, Nowak RM, et al: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167
16. Hobbs FD, Davis RC, Roalfe AK, et al: Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: Cohort study in representative and high risk community populations. BMJ 2002; 324:1498
17. Lubien E, DeMaria A, Krishnaswamy P, et al: Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation 2002; 105:595-601
18. Dahlstrom U: Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 2004; 6:281-287
19. Stanek B, Frey B, Hulsmann M, et al: Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 2001; 38:436-442
20. Hartmann F, Packer M, Coats AJ, et al: NT-proBNP in severe chronic heart failure: Rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Fail 2004; 6:343-350
21. Gardner RS, Ozalp F, Murday AJ, et al: N-terminal pro-brain natriuretic peptide: A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003; 24:1735-1743
22. Fisher C, Berry C, Blue L, et al: N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart 2003; 89:879-881
23. Richards AM, Doughty R, Nicholls MG, et al: Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 2001; 37:1781-1787
24. de Lemos JA, Morrow DA, Bentley JH, et al: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345:1014-1021
25. Richards AM, Nicholls MG, Yandle TG, et al: Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97:1921-1929
26. Witthaut R, Busch C, Fraunberger P, et al: Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: Impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003; 29:1696-1702
27. Charpentier J, Luyt CE, Fulla Y, et al: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660-665
28. Troughton RW, Frampton CM, Yandle TG, et al: Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355:1126-1130
29. Pfister R, Scholz M, Wielckens K, et al: Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 2004; 6:289-293
30. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
31. Raymond I, Groenning BA, Hildebrandt PR, et al: The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003; 89:745-751
32. Ishii J, Nomura M, Ito M, et al: Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 2000; 301:19-30
33. Bernard GR, Artigas A, Brigham KL, et al: Report of the American-European Consensus Conference on acute respiratory distress syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 1994; 9:72-81
34. Herrmann Z, Uhl W, Steinberg HW, et al: The influence of renal function on NT-proBNP levels in various disease groups. Clin Lab 2003; 49:649-656
35. Apple FS, Wu AH, Jaffe AS: European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J 2002; 144:981-986
36. Vanderheyden M, Bartunek J, Goethals M: Brain and other natriuretic peptides: Molecular aspects. Eur J Heart Fail 2004; 6:261-268
37. McLean AS, Huang SJ, Nalos M, et al: The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 2003; 31:2611-2618
38. Berendes E, Van Aken H, Raufhake C, et al: Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg 2001; 93:676-682
39. Suffredini AF, Fromm RE, Parker MM, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321:280-287
40. Dorman T, Breslow MJ, Lipsett PA, et al: Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients. Crit Care Med 1998; 26:1646-1649
41. Pruszczyk P, Kostrubiec M, Bochowicz A, et al: N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 2003; 22:649-653
42. Hammerer-Lercher A, Neubauer E, Muller S, et al: Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001; 310:193-197
43. Hunt PJ, Richards AM, Nicholls MG, et al: Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment. Clin Endocrinol 1997; 47:287-296
44. Yeo KT, Wu AH, Apple FS, et al: Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003; 338:107-115
45. Ammann P, Fehr T, Minder EI, et al: Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001; 27:965-969